SCHOTT Pharma AG & Co. KGaA (ETR:1SXP)
Germany · Delayed Price · Currency is EUR 21.95
+0.15 (0.69%)
At close: Aug 14, 2026
ETR:1SXP Cash Flow Statement
Financials in millions EUR. Fiscal year is October - September.
Millions EUR. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Net Income | 136.09 | 146.45 | 149.69 | 151.84 | 125.38 | 100.75 |
Depreciation & Amortization | 87.61 | 79.44 | 64.98 | 51.85 | 43.79 | 36.44 |
Loss (Gain) From Sale of Assets | -0.16 | -0.33 | -0.59 | -0.39 | -1.51 | -0.3 |
Asset Writedown & Restructuring Costs | - | - | - | -5.2 | 11.57 | - |
Loss (Gain) From Sale of Investments | -0.28 | -0.77 | -1.36 | -0.69 | - | - |
Loss (Gain) on Equity Investments | 2.25 | 2.25 | 4.25 | 2 | - | - |
Other Operating Activities | 3.25 | 1.35 | -4.11 | -2.93 | 27.01 | 10.57 |
Change in Accounts Receivable | -34.66 | -60.85 | -16.96 | -32.43 | -35.57 | -18.5 |
Change in Inventory | 8.34 | -29.46 | -3.41 | -15.38 | -30.64 | -19.06 |
Change in Accounts Payable | -1.37 | 10.05 | 8.47 | -3.9 | 29.11 | 0.87 |
Change in Unearned Revenue | -10.42 | 39.94 | 17.48 | 28.63 | 25.42 | 20.67 |
Change in Other Net Operating Assets | 4.18 | -10.23 | 10.57 | 7.42 | -15.59 | -0.97 |
Operating Cash Flow | 192.89 | 179.92 | 224.77 | 181.65 | 182.12 | 132.21 |
Operating Cash Flow Growth | -5.06% | -19.95% | 23.74% | -0.26% | 37.75% | 26.64% |
Capital Expenditures | -86.8 | -144.32 | -145.08 | -175.47 | -152.01 | -98.07 |
Sale of Property, Plant & Equipment | 1.23 | 1.64 | 1.51 | 4.78 | 12.36 | 1.21 |
Sale (Purchase) of Intangibles | -0.17 | -0.43 | -0.22 | -0.06 | -0.68 | -0.35 |
Investment in Securities | -53.22 | - | -2.14 | -0.66 | -1.81 | -1.35 |
Other Investing Activities | -37.21 | -15.92 | -109.51 | - | - | 2.68 |
Investing Cash Flow | -176.16 | -159.03 | -255.44 | -171.41 | -142.14 | -95.89 |
Long-Term Debt Issued | - | 16.68 | 61.92 | - | 1.04 | - |
Long-Term Debt Repaid | - | -4.79 | -3.56 | -4.25 | -1.54 | -1.59 |
Net Debt Issued (Repaid) | 26.22 | 11.88 | 58.36 | -4.25 | -0.5 | -1.59 |
Common Dividends Paid | -27.11 | -24.1 | -22.59 | -18.88 | -11.46 | -39.82 |
Other Financing Activities | -20.44 | -8.87 | -3.86 | 11.73 | -30.43 | 13.91 |
Financing Cash Flow | -21.33 | -21.08 | 31.91 | -11.4 | -42.38 | -27.51 |
Foreign Exchange Rate Adjustments | 1.2 | -0.52 | -2.42 | -3.28 | 3.33 | 0.44 |
Miscellaneous Cash Flow Adjustments | - | - | - | - | - | 0 |
Net Cash Flow | -3.41 | -0.71 | -1.18 | -4.44 | 0.94 | 9.25 |
Free Cash Flow | 106.09 | 35.6 | 79.69 | 6.19 | 30.11 | 34.14 |
Free Cash Flow Growth | 113.50% | -55.33% | 1188.50% | -79.46% | -11.80% | 77.60% |
Free Cash Flow Margin | 10.44% | 3.61% | 8.33% | 0.69% | 3.67% | 5.26% |
Free Cash Flow Per Share | 0.70 | 0.24 | 0.53 | 0.04 | 0.20 | 0.23 |
Levered Free Cash Flow | 29.66 | -59.03 | -66.1 | 72.63 | -201.87 | -21.3 |
Unlevered Free Cash Flow | 40.03 | -46.99 | -58.11 | 76.79 | -200.55 | -20.56 |
Cash Interest Paid | - | 15.78 | 10.57 | 6.66 | 1.8 | 1.16 |
Cash Income Tax Paid | - | 51.48 | 29.73 | 31.68 | 29.77 | 21.4 |
Change in Working Capital | -35.86 | -48.47 | 11.92 | -14.83 | -24.12 | -15.25 |